Intrahepatic cholestasis and its correction in patients with chronic acalculous cholecystitis
https://doi.org/10.31146/1682-8658-ecg-213-5-66-72
Abstract
Functional disorders of the liver in chronic acalculous cholecystitis, manifested by intrahepatic cholestasis, require therapeutic correction. The aim of the study was to assess the functional state of the liver in patients with chronic acalculous cholecystitis and to develop therapeutic approaches to the identified changes. Materials and methods: 123 patients with chronic heart failure were examined on the basis of the gastroenterology department among the patients there were 90 women and 33 men with the duration of the disease from 5 to 10 years. The average age of patients was 43.74±1.26 years. To clarify the effect of cholestasis on the course of chronic acalculous cholecystitis, all examined patients were divided into two groups: patients chronic acalculous cholecystitis with cholestasis and patients chronic acalculous cholecystitis without cholestasis. The group of patients with cholestasis consisted of 84 people, whose average age was 46.46 (32.67; 60.25) years old, 22.62% were men, 77.38% were women. The group of patients without cholestasis consisted of 39 people with an average age of 43, 56 (28.44; 53.68) years, 13 (33.33%) men and 26 (66.66%) women. Results: the clinical course of chronic acalculous cholecystitis is determined by the presence or absence of intrahepatic cholestasis. Dyskinetic disorders of the gastrointestinal tract and the sphincter apparatus of the biliary tract are more common in patients with cholestasis, which in turn is formed against the background of gallbladder abnormalities in the form of various deformities, and leads to intrahepatic bile stagnation, biliary hypertension. Conclusion: the combined use of metronidazole, hemicromone and ademethionine contributes to the resolution of congestion in the intrahepatic bile ducts, normalization of tone and motor function of the gallbladder and sphincter apparatus of the hepatobiliary tract and reduction of clinical manifestations.
About the Authors
M. V. Pecherskikh
Izhevsk State Medical Academy
Russian Federation
Russian Federation
L. I. Efremova
Izhevsk State Medical Academy
Russian Federation
Russian Federation
References
1. Maev I.V., Bordin D. S., Ilchishina T. A., Kucheryavyy Yu. A. The biliary continuum: an up-to-date look at biliary tract diseases. Meditsinskiy sovet = Medical Council. 2021;(15):122-134. (In Russ.) doi: 10.21518/2079-701X-2021-15-122-134.@@ Маев И. В., Бордин Д. С., Ильчишина Т. А., Кучерявый Ю. А. Билиарный континуум: актуальный взгляд на заболевания желчевыводящих путей. Медицинский Совет. 2021;(15):122-134. doi: 10.21518/2079-701X-2021-15-122-134.
2. Karabaeva V.V., Sidelnikova G. F., Kolkhir V. K. Modern assessment and prospects of the use of Sibectan in the treatment of chronic cholecystitis in outpatient settings. Young scientists and pharmacy of the XXI century: a collection of scientific papers of the III Scientific and Practical Conference with international participation.2015: 449-453. (In Russ.)@@ Карабаева В. В., Сидельникова Г. Ф., Колхир В. К. Современная оценка и перспектива применения «Сибектана» при лечении хронического холецистита в амбулаторных условиях. Молодые ученые и фармация XXI века: сборник научных трудов III Научно-практической конференции с международным участием.2015: 449-453.
3. Benedict M., Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017 Jun 8;9(16):715-732. (In Russ.) doi: 10.4254/wjh.v9.i16.715.
4. Cen L., Pan J., Zhou B., Yu C., Li Y., Chen W., Shen Z. Helicobacter pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: a systematic review and meta- analysis. Helicobacter. 2018;23(1):10.1111/hel.12457. (In Russ.) doi: 10.1111/hel.12457.
5. Mikhaylenko K.A., Ulitina N. N., Fedicheva N. A. Features of changes in biochemical parameters of patients with chronic cholecystitis. Trends in the development of science and education. 2018; (37-5): 35-38. (In Russ.) doi: 10.18411/lj-04-2018-118.@@ Михайленко К. А., Улитина Н. Н., Федичева Н. А. Особенности изменений биохимических показателей больных хроническим холециститом. Тенденции развития науки и образования. 2018; (37-5): 35-38. doi: 10.18411/lj-04-2018-118.
6. Yashnov A.A., Lobanov S. L., Konovalova O. G., Khanina Y. S. Diagnosis of Helicobacter pylori by enzyme immunoassay in patients with calculous cholecystitis. ActaBiomedica Scientifica. 2017;6(2):177-181. (In Russ.) doi: 10.12737/article_5a0a8f7e553367.73063141.@@ Яшнов А. А., Лобанов С. Л., Коновалова О. Г., Ханина Ю. С. Диагностика Helicobacter pylori методом иммуноферментного анализа у больных с калькулезным холециститом. ActaBiomedica Scientifica.2017;6(2):177-181. doi: 10.12737/article_5a0a8f7e553367.73063141.
7. Pankov O.A., Matvienko V. V., Frolkov V. K., et аl. Evaluation of the effectiveness of the use of osteоpathic methods of treatment of patients with chronic stone-free cholecystitis.Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2020.19(2):101-106. (In Russ.) doi: 10.17816/1681-3456-2020-19-2-6.@@ Паньков О. А., Матвиенко В. В., Фролков В. К. и др. Оценка эффективности применения остеопатических методов лечения пациентов с хроническим бескаменным холециститом. Физиотерапия, бальнеология и реабилитация. 2020. 19(2): 101-106. doi: 10.17816/1681-3456-2020-19-2-6.
8. Di Ciaula A., Wang D. Q., Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol. 2019.13(2): 157-171. doi: 10.1080/17474124.2019.1549988.
9. Nassar Y., Richter S. Management of complicated gallstones in the elderly: comparing surgical and non-surgical treatment options. Gastroenterol Rep (Oxf). 2019. 7(3).:205-211. doi: 10.1093/gastro/goy046.
10. Ochoa E. S. S. Gutierrez M. E. D., Rocha A. L., et al. Gallbladder perforation with liver abscess; laparoscopic cholecystectomy converted to open: a case report.International Journal of Research in Medical Sciences. 2021.9(12):3685-3688. doi: 10.18203/2320-6012.ijrms20214719.
11. Wanjura V., Sandblom G. How Do Quality-of-Life and Gastrointestinal Symptoms Differ Between Postcholecystectomy Patients and the Background Population? World J Surg. 2016. 40(1): 81-8. doi: 10.1007/ s00268-015-3240-0.
12. Wu X.D., Tian X., Liu M. M., et al. Meta-analysis comparing early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br. J. Surg. 2015. 102 (11):1302-1313.doi: 10.1002/bjs.9886.
13. Volevach L.V., Guryev R. D., Demidova N. A., Garipova R. A., et al. Clinical picture and assessment of eating behavior in persons with biliary pathology with increased weight. Medical Bulletin of Bashkortostan. 2020;15(5-89): 22-25. (In Russ.)@@ Волевач Л. В., Гурьев Р. Д., Демидова Н. А., Гарипова Р. А. и др. Клиническая картина и оценка пищевого поведения у лиц с билиарной патологией при повышенном весе. Медицинский вестник Башкортостана. 2020;15(5-89): 22-25.
14. Vlasov A.P., Sheiranov N. S., Vlasova T. I., et al. Liver damage in acute destructive cholecystitis. Modern problems of science and education. 2017; (5): 187. (In Russ.)@@ Власов А. П., Шейранов Н. С., Власова Т. И. и др. Поражение печени при остром деструктивном холецистите. Современные проблемы науки и образования. 2017; (5): 187.
Review
For citations:
Pecherskikh M.V., Efremova L.I. Intrahepatic cholestasis and its correction in patients with chronic acalculous cholecystitis. Experimental and Clinical Gastroenterology. 2023;(5):66-72. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-213-5-66-72
Views:
105
Email this article 